It will be a pleasure to meet you in the next BIOJAPAN (Oct 12 – 14 2022) that will take place in Yakoama. We will be present on our partner’s booth, AS ONE corp. (H29).

Find HCS Pharma in BIOJAPAN 2022!

Thanks to our partners in Asia, AS ONE corp. and JVC Kenwood corp. and our distributor Tokyo Future Style Taiwan, we will be present in the 2022 edition of BIOJAPAN to present our technology BIOMIMESYS® to Asian customers. It will be a unique opportunity to develop our contacts because this edition combines three events, “BIOJAPAN”, “Regenerative Medicine JAPAN” and “health TECH JAPAN”.

During these 3 days, from October 12 to October 14, we will be on AS ONE corp.’s booth (H29) to explain the BIOMIMESYS® technology and to show usages. We will also participate in multiple meetings with pharmaceutical companies to develop our Asian market. The 1 on 1 matching system of the congress is incredibly efficient!

This is the first step of our business travel in Asia. We will continue next weeks in Singapore to participate to the Singapore Week of Innovation and Technology (SWITCH) 2022, and after we will be in Taiwan to meet our local customers.

We hope to see you in BIOJAPAN, feel free to book a meeting!


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

0 Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.